The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 37, No. 1, pp. 122-126. DOI 10.1345/aph.1C118
© 2003 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lata, P. F
Right arrow Articles by Pigarelli, D. L W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lata, P. F
Right arrow Articles by Pigarelli, D. L W.

DRUG INFORMATION ROUNDS

Chronic Metoclopramide Therapy for Diabetic Gastroparesis

Paul F Lata, PharmD

Clinical Pharmacist, Case Management Services, Bay Area Medical Center, Marinette, WI

Denise L Walbrandt Pigarelli, PharmD

Clinical Assistant Professor, University of Wisconsin–Madison School of Pharmacy; Clinical Pharmacist, William S Middleton Memorial Veterans Affairs Hospital, Madison, WI

Reprints: Paul F Lata PharmD, Case Management Services, Bay Area Medical Center, 3100 Shore Dr., Marinette, WI 54143-4242, FAX 715/735-8040, E-mail plata{at}bamc.org

OBJECTIVE: To review the safety and efficacy of chronic metoclopramide for diabetic gastroparesis.

DATA SOURCES: Medical literature was accessed through MEDLINE (1965 to October 2002) and PubMed (1965 to October 2002). Key search terms included metoclopramide; diabetic gastroparesis; and dyskinesia, drug induced.

DATA SYNTHESIS: Metoclopramide is often used for diabetic gastroparesis, despite the risk of tardive dyskinesia. Published information is limited regarding long-term efficacy and toxicity of metoclopramide. The literature was assessed concerning these topics.

CONCLUSIONS: Limited data do not provide sufficient evidence to conclude whether metoclopramide is efficacious for chronic use. Routine monitoring may mitigate the risk associated with metoclopramide therapy.

Key Words: diabetic gastroparesis, metoclopramide, tardive dyskinesia

www.theannals.com, DOI




homecopy help contact us subscription past issues search current issue
Copyright © 2003 by Harvey Whitney Books Company.